相关实验视频

Updated: Jun 25, 2025

Analysis of Human T Cell Activity in an Allogeneic Co-Culture Setting of Pre-Treated Tumor Cells

Analysis of Human T Cell Activity in an Allogeneic Co-Culture Setting of Pre-Treated Tumor Cells

Published on: March 7, 2025

癌细胞代谢的免疫学方面

Sisca Ucche^1,2, Yoshihiro Hayakawa¹

¹Institute of Natural Medicine, University of Toyama, Toyama 930-0194, Japan.

International journal of molecular sciences

|May 25, 2024

概括

癌细胞重编程新陈代谢以逃避免疫检测,并复杂化癌症治疗. 针对这些代谢途径可以提高免疫治疗对瘤的有效性.

科学领域:

在瘤学瘤学.
免疫学免疫学免疫学
代谢研究研究代谢研究

背景情况:

癌细胞表现出代谢重编程以逃避免疫监测.
瘤微环境 (TME) 相互作用对于癌症的进展和免疫规避至关重要.

研究的目的:

审查癌细胞代谢在免疫逃避中的作用.
探索瘤和免疫细胞之间的代谢竞争及其对免疫治疗的影响.
确定代谢途径作为潜在的治疗点.

主要方法:

文献综述整合癌细胞代谢和免疫反应的研究.
癌细胞使用的代谢重编程策略的分析 (例如,华堡效应,谷氨胺成).
检查TME内部的代谢竞争.

主要成果:

癌细胞操纵葡萄糖和氨基酸代谢,在免疫压力下壮成长.
代谢重编程有助于免疫抑制的TME.
代谢竞争影响了当前免疫疗法的疗效.

结论:

破坏癌细胞代谢途径是增强免疫疗法的有希望的策略.
针对癌症新陈代谢提供了一种双重方法来对抗瘤生长和免疫逃避.

关键词:

癌症癌症癌症癌症癌症免疫系统的逃脱是免疫逃脱.免疫监测监测是指免疫系统的监测.代谢代谢代谢代谢这是一个渐进的过程.

更多相关视频

Monitoring the Cancer-Immunity Cycle and Exploring Tumor Microenvironment Dynamics

Monitoring the Cancer-Immunity Cycle and Exploring Tumor Microenvironment Dynamics

Published on: June 7, 2024

Assessment of the Metabolic Profile of Primary Leukemia Cells

Published on: November 21, 2018

相关概念视频

Adaptive Mechanisms in Cancer Cells

Adaptive Mechanisms in Cancer Cells

Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...

Cancer Stem Cells and Tumor Maintenance

Cancer Stem Cells and Tumor Maintenance

Early diagnosis and treatment can often cure cancer. However, even with treatment, residual cells called cancer stem cells (CSC) might remain, often causing tumor recurrence. These cancer stem cells possess the potential for self-renewal and multi-lineage differentiation and are often responsible for the therapeutic resistance displayed in most cancers.
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...

Tumor Immunotherapy

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.

The Tumor Microenvironment

The Tumor Microenvironment

Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...

mTOR Signaling and Cancer Progression

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...

Metastasis

Metastasis

Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...